Incannex Healthcare (IXHL) Research & Development (2022 - 2026)
Incannex Healthcare (IXHL) posted Research & Development of $321000.0 for Q1 2026, down 85.92% sequentially from $2.3 million in Q4 2025, and down 88.26% YoY from $2.7 million in Q1 2025.
Incannex Healthcare (IXHL) Research & Development (2022 - 2026) Analysis & Trends
Incannex Healthcare has reported Research & Development for 5 years, with the latest figure at $321000.0 in Q1 2026.
- Quarterly Research & Development fell 88.26% year-over-year to $321000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.4 million (down 34.91% YoY) and the FY2025 annual result came in at $10.7 million, down 16.55% from the prior year.
- Research & Development declined to $321000.0 in Q1 2026 per IXHL's latest filing, from $2.3 million in the prior quarter.
- Over five years, Research & Development peaked at $4.4 million in Q2 2024 and troughed at $321000.0 in Q1 2026.
- A 5-year average of $2.3 million and a median of $2.4 million in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2024 and 2026: Research & Development surged 154.61% in 2024, then plunged 88.26% in 2026.
- Over 5 years, Research & Development stood at $1.5 million in 2022, then surged by 70.3% to $2.6 million in 2023, then tumbled by 46.4% to $1.4 million in 2024, then soared by 61.24% to $2.3 million in 2025, then sank by 85.92% to $321000.0 in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $321000.0, $2.3 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Incannex Healthcare | 41.37 Mn | 41.37 Mn | - | 321,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 321,000.00 |
| Dec 31, 2025 | 2.28 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 3.70 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 4.36 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | 2.64 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 1.71 Mn |
| Mar 31, 2023 | 1.64 Mn |
| Dec 31, 2022 | 1.55 Mn |